Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Report Incorrect Product Information Incorrect Product Information Thank You
Alternative diabetes treatments include other GLP-1 agonists (if no cross-reactivity), SGLT2 inhibitors, DPP-4 inhibitors, or insulin therapy per NICE NG28 guidance
Because of that, interest has grown around BPC 157, an experimental peptide often discussed in relation to tissue healing and recovery
50 Next-Generation Modalities: Small Molecules and Poly-Agonists As the patent cliffs for current GLP-1 peptides approach, the industry is racing to develop next-generation assets that can achieve higher efficacy, better adherence, and refreshed IP protection
US$ 27.70
US$ 28.30
US$ 29.45
US$ 25.90
US$ 20.30
US$ 23.69
US$ 24.79
US$ 24.95
US$ 22.05
